Literature DB >> 25325577

Asenapine-induced restless legs syndrome: differentiation from akathisia.

W Vaughn McCall1, Mary Anne Riley1, Chelsea Hodges1, Laryssa McCloud1, Marjorie Phillips2, Peter B Rosenquist1.   

Abstract

Akathisia and restless legs syndrome (RLS) share some common clinical features and a common relationship with dopamine dysfunction. However, the underlying causes and appropriate treatments for akathisia and RLS are different. Herein we describe a case of RLS that was precipitated by a single dose of asenapine, which is an atypical antipsychotic, and dissect the features that support the contention that this was indeed a case of RLS and not akathisia.
© 2014 American Academy of Sleep Medicine.

Entities:  

Keywords:  akathisia; asenapine; restless leg syndrome

Mesh：

Substances：

Year:  2014        PMID： 25325577      PMCID： PMC4237529          DOI： 10.5664/jcsm.4296

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


  8 in total

1.  Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

Authors:  Simon Cervenka; Sven E Pålhagen; Robert A Comley; Georgios Panagiotidis; Zsolt Cselényi; Julian C Matthews; Robert Y Lai; Christer Halldin; Lars Farde
Journal:  Brain       Date:  2006-07-01       Impact factor: 13.501

2.  A case of akathisia induced by escitalopram: case report & review of literature.

Authors:  Bishan Basu; Tanmoy Gangopadhyay; Nivedita Dutta; Bidyut Mandal; Sumitava De; Srikrishna Mondal
Journal:  Curr Drug Saf       Date:  2014-03

3.  Restless leg syndrome associated with olanzapine: a case series.

Authors:  Shilpa Aggarwal; Seetald Dodd; Michael Berk
Journal:  Curr Drug Saf       Date:  2010-04

Review 4.  Asenapine: a clinical review of a second-generation antipsychotic.

Authors:  Steven C Stoner; Heather A Pace
Journal:  Clin Ther       Date:  2012-04-10       Impact factor: 3.393

Review 5.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

Review 6.  Akathisia and second-generation antipsychotic drugs.

Authors:  Rajeev Kumar; Perminder S Sachdev
Journal:  Curr Opin Psychiatry       Date:  2009-05       Impact factor: 4.741

Review 7.  Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics.

Authors:  Heike Benes; Arthur S Walters; Richard P Allen; Wayne A Hening; Ralf Kohnen
Journal:  Mov Disord       Date:  2007       Impact factor: 10.338

Review 8.  Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database.

Authors:  Santiago Perez-Lloret; María Verónica Rey; Emmanuelle Bondon-Guitton; Olivier Rascol; And Jean-Louis Montastruc
Journal:  J Clin Psychopharmacol       Date:  2012-12       Impact factor: 3.153
  8 in total
  1 in total

Review 1.  The Other Obesity Epidemic-Of Drugs and Bugs.

Authors:  Adonis Sfera; Carolina Osorio; Eddie Lee Diaz; Gerald Maguire; Michael Cummings
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.